Pictured: Emma Burrows, Legal, Regulation and Corporate Affairs Director, Bord Gáis Energy
This week sees new and notable appointments at Bord Gáis Energy, Boyden, PM Group, and Signum Surgical
Emma Burrows, Legal, Regulation and Corporate Affairs Director,
Bord Gáis Energy
Bord Gáis Energy, the energy and services provider, has announced the appointment of Emma Burrows as its new Legal, Regulation and Corporate Affairs Director with immediate effect and joining the Executive Management Team of Bord Gáis Energy.
Emma will be taking over the position from Joanne Ross who has been appointed as Chief of Staff to the CEO of Bord Gáis Energy’s parent company, Centrica PLC.
Emma joined Bord Gáis Energy in 2012 from private practice and since then she has supported and advised the business on a wide range of legal matters, leading the legal team since 2017. Prior to joining the Company, she was in private practice with Lavelle Coleman, prior to which she had spent 6 years with A&L Goodbody where she qualified as a solicitor in 2002.
In addition to her extensive industry expertise and successful career, Emma is a keen supporter of Bord Gáis Energy’s Focus Ireland partnership to tackle family homelessness in Ireland and has been part of the steering committee for the past couple of years.
Dave Kirwan, Managing Director at Bord Gáis Energy said: “I am delighted to welcome Emma to her new role and as part of the leadership team that is continuing to drive our growth and transformation in Bord Gáis Energy as we focus on leading the provision of energy and energy services to homes, businesses and communities across Ireland. At Bord Gáis Energy investing in our people is a key priority for us and this is a richly deserved promotion. Emma is bringing a wealth of experience and expertise to the role and will be advising on the full range of regulatory, legal and corporate affairs issues.”
Commenting on her appointment, of Emma Burrows said, “I am honoured to be appointed as the new Legal, Regulation, and Corporate Affairs Director of Bord Gáis Energy as we head into an exciting future redefining our sustainable business strategy. I am also delighted to join the leadership team that is central to the growth and transformation of the company. Having worked in Bord Gáis Energy for almost a decade, I have seen a huge amount of change over that time and look forward to playing an integral role in implementing further developments and innovations across the company over the coming years.”
Kevin Keegan, Partner,
Maurice Carr, Partner,
Boyden, a Forbes top 10 leadership and talent advisory firm with more than 75 offices in over 45 countries, announces the opening of its Dublin office. Led by Partners Kevin Keegan and Maurice Carr, Boyden Ireland provided expertise in executive search, interim management and leadership consulting.
Upon making the announcement, Nick Robeson, Managing Partner of Boyden UK & Ireland, commented, “Ireland has consolidated its position as a bridgehead for Europe and has significant potential both for our existing clients and domestic Irish firms. We are delighted that Kevin and Maurice have joined the team at this pivotal time in our organisation’s development. There is powerful synergy between us all and as we move to a post vaccine world we look at the year with renewed optimism and energy”.
Keegan is a leading specialist in strategic talent acquisition, Human Resources and organisational development in high growth dynamic and transforming environments. Previously he held HR Director positions with Digicel, Ulster Bank, Greencore and Kerry Group. An Organization Psychologist with over 20 years international HR Leadership experience he brings a unique and valuable perspective to the Boyden proposition.
“I am delighted to join a global firm that excels in sourcing and aligning world class executive talent to organisations,” said Kevin Keegan, Partner, Boyden Ireland.
Carr is a long-term expert in executive search and champion of interim management. He was previously Partner – Executive Recruitment at leading accountancy firm, BDO, in Ireland. He is a professional coach, certified by ICF, and a Fellow of Chartered Accountants Ireland.
“I was attracted to Boyden’s client-focused culture and strategic approach to building leadership teams,” said Maurice Carr, Partner, Boyden Ireland. “In both search and interim management, I focus on the broader organisational impact, with client needs front of mind at every stage of the journey”.
Rosita Fennell, Chief Financial Officer,
PM Group, the international project delivery company, announces the appointment of Rosita Fennell as Chief Financial Officer as well as being appointed to its Board of Directors. PM Group is an award-winning international project delivery firm with over 3,000 people worldwide.
Rosita is a chartered management accountant and holds a Bachelor of Commerce degree from University College Cork and an MSc in Executive Leadership from University of Ulster. Rosita has held a number of senior finance roles in a variety of multinational companies prior to joining PM Group in 2006. With her extensive experience of finance and operations management, Rosita has supported PM Group’s growth and development in a number of finance leadership roles and served as Company Secretary from 2019 to 2021.
Dan Flinter, Chair of PM Group said: “Rosita’s strategic, financial and operations experience will be a significant addition to the PM Group Board of Directors. As an employee owned business working across the world, Rosita will play an important role in PM Group’s future development”.
PM Group Chief Executive, Dave Murphy also welcomed the appointment, saying: “I am delighted with the appointment of Rosita and wish her well in her new role as CFO and as a fellow Director on the Board of PM Group. I look forward to working with Rosita as we continue to grow and develop our international business.”
Larry Westman who has served as CFO of PM Group and Board member since 2001, and contributed hugely to the Group’s development, will continue to work with the Group in an advisory capacity.
Dr Bernard Collins, Non-Executive Director of the Board,
Signum Surgical, the medical technology company developing innovative solutions to treat colorectal diseases, today announces the appointment of Dr Bernard Collins as a Non-Executive Director of the Board.
Dr Collins is a leading expert in the medical technology sector and serves on the Board of Directors of several US and Irish life-science companies including, CroíValve, Aerogen, Atlantic Therapeutics and Vivasure Medical. A former Vice President of International Operations for Boston Scientific, where he served for 10 years, Dr Collins has held a number of senior executive positions in international lifescience companies during his career, including at Baxter Healthcare.
Jeff Grainger, Chairman of Signum Surgical, commented: “We are delighted to welcome Bernard to the Board. As we continue to progress our regulatory and clinical programmes, Bernard brings a wealth of commercial experience and technical expertise at an important time for the company. We look forward to his contribution.”
Dr Bernard Collins, Non-Executive Director of Signum Surgical, commented: “I’m excited to join the Board of Signum Surgical and look forward to helping the team accelerate its regulatory and commercial objectives. I believe in Signum Surgical’s innovative BioHealx technology as an effective and viable treatment option for physicians, which has the potential to transform the lives of patients suffering from an anal fistula.”
Headquartered in Galway, Signum Surgical is focused on developing minimally invasive technologies to treat colorectal diseases, principally a condition known as anal fistula. This painful, and often recurring colorectal condition, which severely affects patients’ quality of life, involves the infection of an internal gland. Affecting one in 5,000 people worldwide, patients and their physicians are dissatisfied with the efficacy of current treatment options, which are rarely successful, and can leave patients suffering with ongoing infections which require repeat procedures.
Developed in collaboration with expert colorectal surgeons, Signum Surgical’s proprietary BioHealxTM technology, which enables surgeons to treat anal fistula with a minimally invasive outpatient procedure, features a single use, bioabsorbable, implant that is designed to help seal the fistula tract and dissolve in the body after treatment. The single-operation approach is designed to promote healing, prevent reinfection, and protect patient continence.